SCHEMBL7205283

SCHEMBL7205283

COc1cc(C=CC=C(C#N)NC(C)c2ccccc2)c(OC)cc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.56
MEN1 O00255 7/20 0.56
MAPT P10636 8/20 0.39
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 6/20 0.39
TP53 P04637 4/20 0.39
MAPK1 P28482 3/20 0.39
HSD17B10 Q99714 3/20 0.39
CYP3A4 P08684 3/20 0.39
ALOX15 P16050 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
RGS12 O14924 2/20 0.39
GMNN O75496 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
TSHR P16473 2/20 0.39
ALOX12 P18054 2/20 0.39
NFKB1 P19838 2/20 0.39
CYP2C19 P33261 2/20 0.39
THPO P40225 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7204112 0.83 KMT2A (0.61) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL7205287 0.78 MAPT (0.47) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL7191088 0.75 NFE2L2 (0.38) KMT2AMEN1MAPTALDH1A1EGFR
SCHEMBL7191091 0.75 NFE2L2 (0.38) KMT2AMEN1MAPTALDH1A1EGFR
SCHEMBL7065127 0.72 KMT2A (0.48) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL7205277 0.70 SLC16A3 (0.40) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL7166663 0.69 KMT2A (0.48) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL4483004 0.69 KMT2A (0.77) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL4482998 0.69 KMT2A (0.77) KMT2AMEN1MAPTALDH1A1KDM4E
SCHEMBL4495472 0.67 KMT2A (0.74) KMT2AMEN1MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030109502-A1 Novel compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2003-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109502-A1 Novel compounds for modulating cell proliferation MKI67, CCNA1, CCNI KMT2A 3487/4885MEN1 1705/4885MAPT 4740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.